Several studies have shown support from the public toward Background. the use of medicinal marijuana. In this cross-sectional study, we assess the risk perception to medicinal marijuana in a sample of medical students.
Introduction
Several studies have showed the potential benefits of medicinal marijuana (MM) for the treatment of some illnesses, such as pain in cancer, multiple sclerosis, Alzheimer's disease, post-traumatic stress disorder, epilepsy, Crohn's disease, and glaucoma 1, 2 . However, like other drugs, MM is not exempt from serious adverse effects, such as psychiatric disorders, euphoria, disorientation, confusion, somnolence, and fatigue; therefore, it should be used with extreme caution 3 . Legally, physicians cannot prescribe MM; however, in some countries, they can recommend its use when they consider it necessary. Some recommendations on how to prescribe marijuana for the care of patients have been published previously 4 .
On the other hand, risk perceptions towards medicinal drugs have been reported that influence in the prescribing behavior and the willingness of physicians to report adverse drug reactions. Knowing the risk perceived by medical students to drug prescription is important, since it establishes the requirement of education regarding certain medicines, like MM. In this respect, there are no studies regarding the risk perception toward MM in the general population and among health professionals. The existing literature has focused mainly on attitudes and support toward its legalization. Across countries, the factors associated with support for its legalization are political tolerance, ideology, and the views toward government 5 .
In Mexico, as in others countries, the use of MM was prohibited; however, in December 2016, the Senate approved the legalization of MM and sent the bill to the Chamber of Representatives for ratification, which occurred on April 28, 2017. The next steps for its appropriate use include the publication of laws, regulations, and guidelines by the Health Ministry, medical schools, and medical associations. While this continues, it is important that health professionals be updated on this topic, so that they can rationally recommend the use of MM. To achieve this, a first approach would be to know the attitudes and willingness to recommend the use of MM, and the risk perceived by physicians. In this study, we evaluate the risk perception of MM in medical students from northeast Mexico and determine associated factors.
Methods

Study design
A cross-sectional study that uses a visual scale to estimate risk perception of MM. The survey was applied during July and August 2017 in a public university from northeast of Mexico.
Participants
The inclusion criteria were as follow: Medical students of Universidad Autónoma de Nuevo León, both genders, any semester of study, and ages older than 18 years. Participants with incomplete surveys of second section were excluded. The medical students were contacted personally in the study areas and halls of the Faculty of Medicine. After obtaining verbal consent the survey was applied. This was self-administered with supervision. This study was performed in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Faculty of Medicine at Universidad Autónoma de Nuevo León (registration number PI17-00134). Only verbal consent was requested from participants because the study is of low risk. This type of consent was approved by the Ethics Committee.
Instrument
The survey used was composed of two sections, the first section, which was optional, collected demographic information, such as age, gender, semester of study, self-reported alcohol and smoking status (undefined level, only yes or no), and currently selfreported disease (unspecific, only yes or no). The second section evaluates the risk perception toward the use of MM. For this, a visual scale of 10 cm, from 0 cm (without risk) to 10 cm (completely risky), was used. Participants marked over the scale the risk that they perceived when MM is used. This section also contained two additional scales for paracetamol and sedatives, which act as relatively safe (negative control) and risky (positive control) drugs, respectively. The order of scales, including MM, was randomly allocated. The use of this visual 10-cm scales has been used previously in studies that assess the risk perception to other medicinal drugs [6] [7] [8] . The complete survey is available as Supplementary File 1.
Statistical analysis
Descriptive statistics is reported for demographic data. Risk perception was reported as the median of centimeters marked over the scale (from 0 to the mark). The results of risk perception were grouped by three age groups (18-20, 21-23 and >23 years), gender, semester of study (1-3, 4-7 and >7 semester), and selfreported alcohol and smoking status. Differences among groups were evaluated with the Mann-Whitney and Kruskal-Wallis tests, as appropriate. The statistical package NCSS version 11 was used for all analysis. The level of significance was p < 0.05.
Results
Overall, the rate of response was 97%. In total 283 students were interviewed, of which 50.8% were men; 61% had an age range of 21-23 years, and 62.8% were enrolled in semesters 8 or higher. In addition, 18.7% self-reported smoking, 48.1% consuming alcohol and 14.1% self-reported having a (unspecified) disease (Table 1) .
Overall, the risk perception of MM was 4.22 cm, while for paracetamol and sedatives it was 1.56 and 5.00 cm, respectively ( Figure 1 ). The observed differences among the three drugs were statistically significant (P < 0.05). This pattern was similar according to gender, age, semester of study, smoking and alcohol consumption and having some (unspecified) disease.
The analysis of individual drugs did not show a significant difference between gender, smoking and alcoholism status, having a disease, or among age groups and the semester of study in the risk perception of paracetamol and sedatives (Table 2) . However, a significant difference was observed between self-reported smoking and alcohol consumption in the risk perception of MM. Those that self-reported smoking or alcoholism had a lower risk perception of MM. 
Discussion
In this study, we assessed the risk perceived by medical students toward the use of MM. Previous reports have analyzed the risk perception to several drug prescriptions; however, this is the first study that analyzes the risk perception to MM using the same instrument that these studies used.
Although several studies in the general population and among health professionals have shown a support for the legal use of MM [9] [10] [11] [12] , physicians undoubtedly require solid knowledge of both its benefits and adverse effects if they want recommend it appropriately. Our results show that the risk perceived to MM (4.2 cm) is higher than paracetamol but lower than sedatives in Mexican medical students. Compared with other studies, the risk perceived is similar to the risk perceived to antibiotics, hypocholesterolemia drugs, and antihypertensives (median range 3-5 cm), but lower than that to nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants, and anticoagulants (median > 6 cm) [6] [7] [8] 13 . Although the objective was not to establish whether perceived risk was adequate, we speculate that observed outcome is low. We think that a reasonable risk perception of MM should be more than 6, close to other drugs as sedatives, antidepressants or anticoagulants.This due to the difficulty of dosing, specifically if it is smoked, and the frequency of adverse effects of MM. We speculate that students with risk perception values of MM lower than 5 could underestimate its adverse effects and probably could recommend it indiscriminately during their practice. More studies concerning this are needed.
On the other hand, the risk perception of paracetamol was low and is similar to that previously reported 14 . The implications of this finding could be the same as with MM; students could underestimate its adverse effects, which is mainly liver damage 15 . It is worth remembering that lack of awareness of potential harm from taking or administering paracetamol improperly in adults and adolescents is a cause of emergency department visits 16 . An interesting result was the significant difference in risk perception between those that self-reported smoking and alcohol consumption. The users of these recreational drugs had a lower risk perception of MM. In this sense, it has been proven in previous studies that tobacco and alcohol consumption are risk factors for the use of recreational marijuana 17, 18 . In addition, the consumption of these drugs has been associated with support for legalization of recreational and MM 19, 20 .
The risk perception observed could be due in part to attention from mass media regarding its potential uses. Previous studies have found an association between public support for MM and its coverage in media 21, 22 . Another factor that could impact risk perception values, is the lack of formal courses regarding MM in the syllabus of students surveyed 23 . In this sense, previous studies have proven that formal courses of pharmacology increase risk perception toward common drugs like NSAIDs 7 . The design and implementation of formal courses regarding MM may have the same impact.
Finally, we consider that our results should be interpreted with caution, as it is possible that our findings may not be generalized to other countries, due to differences in teaching methods. Replication in others countries, especially where the use of MM has been recently made legal, is needed. Although the risk perception of drugs has been studied with visual scales, the development of other instruments could improve the assessment.
Conclusions
The risk perception of MM was 4.22 in medical students of the northeast of Mexico. With the legalization of MM in Mexico, formal courses regarding dosing, and adverse and beneficial effects of MM will be needed in medical schools.
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However, in its current state, the manuscript is unfit for publication. The introduction is insufficiently supported by evidence, and contains several grammatical and structural mistakes that make it very difficult to read. The aims and objectives of the study are not clearly stated. The methodology has several gaps and generally lacks in rigor. Specifically, the question asked to study participants is unclear ("What is the level of risk associated with medicinal marijuana") as participants are not told what type of risk we are concerned about. The discussion section also has several grammatical mistakes, includes several statements that are not supported by evidence, and does not adequately explain the significance of the findings. Also, the authors fail to underline key limitations in their study. Finally, the conclusions are not appropriately related to study data and lack in clinical relevance.
All in all, the authors have attempted to research an important issue, but the level of rigor in their investigation is insufficient. The survey designed by the authors fails to ask a clear question to study participants and the very high number of grammatical mistakes in the manuscript severely impacts readability. We recognize the effort that was put into this study, and congratulate the authors for selecting an important and timely topic, but cannot recommend publication of this manuscript.
Detailed comments:
Consider changing the term medicinal marijuana to medical marijuana (this term is more commonly used in North America).
Abstract:
In the results section, the authors should clearly state that students who used alcohol or cigarettes had a lower risk perception of marijuana. Also, authors need to specify the units of the risk perception scale of put it into context. The conclusions need to be rephrased. A score of 4.22 on a visual analogue scale does not have any clinical or practical significance in and of itself.
Introduction:
The text has several grammatical and syntactic mistakes that make it difficult to read. Several statements in the Introduction are not supported by a reference. This needs to be addressed. The second paragraph is very difficult to read and needs to be rewritten. In the third paragraph, the authors appear to support the recommendation of medical marijuana for patients ("…so that they can rationally recommend the use of MM…"). Authors refrain from making recommendations based on personal opinion or rewrite this sentence so that it appears neutral. The aims and objectives of the study are not clearly stated and should be clearly described.
Methods:
The first sentence is grammatically incorrect and needs to be revised. Participants: The reason for exclusion of participants with incomplete data is unclear (this data needs to be reported). The sentence where this is stated is ambiguous and grammatically incorrect. Authors need to detail who obtained consent and who was providing supervision while participants were filling in their surveys as this could be a significant source of bias. Also, was privacy respected? This is a critical point.
Were surveys administered anonymously? This needs to be stated explicitly in the manuscript. It is unclear why the authors refer to the Declaration of Helsinki, this should be removed. Instrument: It is unclear why the demographic section was optional. This highly impacts the results of the study.
It is unclear why the authors asked participants about having a disease. Authors should say more explicitly how they asked the question on perceived riskiness of medical marijuana (this should appear in the methodology section).
Results:
In Table 1 , authors need to be more specific about how much data is missing as this could introduce a source of bias It is unclear what the response rate represents. Is it referring to the proportion of students who were offered to participate or is it the proportion of medical students at the medical school?
In Figure 1 , authors state that paracetamol is safe and that sedatives are risky. This should be supported by evidence. Table 2 would benefit from more detail in the row headers as they are hard to interpret. Also, authors should include interquartile ranges in Table 2 . Finally, it is not clear what the p-values for the rows in Table 2 are comparing -highest to lowest values would mean comparing paracetamol to sedatives -presumably that is not what authors mean.
The term "control" is inadequate in this context. While there is no statistically significant difference between semester of study, it looks like there could be a difference between students early in their studies (1-3) vs >4 if the data were dichotomized in this way. That could be interesting because it might suggest that as students learn more in school they become more aware of the risks of marijuana use.
Discussion:
The first sentence of the discussion should summarize the authors' research findings. Authors should acknowledge that there is a high level of controversy around the use of medical marijuana.
The authors compare the results of their study with results from other studies. This comparison needs to be detailed. Were all the studies asking the exact same question?
The comment in the discussion that the "risk is too low and should be closer to 6" seems to have no justification, and should be removed (if the manuscript is to be edited). This is strictly the authors' speculation about a scale that has even been validated for this type of experiment (or has it? If it has been this needs to be mentioned in the manuscript) -in other words we don't even know what a 6/10 means, nor is there any evidence that the scale is anything more than ordinal. If the authors have more data about the scale and its validity they should include it. The authors fail to recognize several methodological limitations in their study (ie: missing data, mode of recruitment, one single medical school...). The authors' explanation of why the fact that students who use alcohol or cigarettes have lower risk perception is an interesting finding is incoherent. The authors appropriately recognize opportunities for education but could make better use of study data to support their point. Ex: mention that the risk perception of MM does not change with the number of school semester, suggesting a potential missed opportunity in medical education, as students should become more aware of the risks of recommending MM if taught about those risks. The authors appropriately recognized that the study findings might not be generalizable to other countries, but should also acknowledge that they have surveyed students and not healthcare providers.
In general, the discussion lacks in depth and clinical relevance.
Finally there is no sense of the relevance of this data. Are higher risk perceptions associated with less frequent recommendations for other substances or are they associated with some other meaningful impact on provider behavior? Without this, the data is decontextualized and not easy to meaningfully interpret. marijuana (this should appear in the methodology section).
The specific question will be written in the method section. However, you can find it in Response. the survey, which is provided as a supplementary file.
RESULTS
In Figure 1 , authors state that paracetamol is safe and that sedatives are risky. This should be supported by evidence.
In Figure 1 we do not affirm that paracetamol and sedative are completely safe and Response. risky respectively. We state that two additional scales were included for paracetamol and sedatives which act "RELATIVELY" safe and risky control. We agree with the term control is inadequate in this context and will be removed.
While there is no statistically significant difference between semester of study, it looks like there could be a difference between students early in their studies (1-3) vs >4 if the data were dichotomized in this way.
Thank you very much for your observations. We will consider dichotomies as you Response. recommend.
DISCUSSION
The comment in the discussion that the "risk is too low and should be closer to 6" seems to have no justification, and should be removed (if the manuscript is to be edited). This is strictly the authors' speculation about a scale that has even been validated for this type of experiment (or has it? If it has been this needs to be mentioned in the manuscript) -in other words we don't even know what a 6/10 means, nor is there any evidence that the scale is anything more than ordinal. If the authors have more data about the scale and its validity they should include it Thank you very much, we have clearly written in the paragraph that "we speculate" at Response. this respect and expose our reasons. In addition, we recommend more studies at this respect in the last sentence.
Finally there is no sense of the relevance of this data. Are higher risk perceptions associated with less frequent recommendations for other substances or are they associated with some other meaningful impact on provider behavior? Without this, the data is decontextualized and not easy to meaningfully interpret.
With respect to MM there is no data. However, we comment the association of risk Response. perception of medicinal drugs with behaviors of physicians in the second paragraph of introduction (it will be more referenced). These paragraph will be placed in discussion section for improve the sense of relevance.
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